Long-Term Treatment of Overweight and Obesity with Polyglucosamine (PG L112): Randomized Study Compared with Placebo in Subjects after Caloric Restriction
Short-term treatment of overweight and obesity with polyglucosamine (PG) was
found to be more effective than placebo and orlistat in double-blind clinical studies.
Randomised, double-blind, clinical investigation to compare orlistat 60 milligram and a customized polyglucosamine, two treatment methods for the management of overweight and obesity
The efficacy of a non-prescription drug to support weight loss programs has yet to be compared.
This clinical trial investigates the comparability of orlistat 60 milligram (mg) and polyglucosamine.
A single oral dose of a polyglucosamine influences the bioavailability of [9-14C]- Oleic acid in adult female Göttingen minipigs
The objective of this study is to investigate the influence of polyglucosamine on the bioavailability of the model compound [9-14C]-oleic acid in female Göttingen minipigs.
Efficacy of polyglucosamine for weight loss—confirmed in a randomized double-blind, placebo-controlled clinical investigation
The purpose of this clinical study was to ascertain whether low molecular weight chitosan polyglucosamine is able to produce significantly better weight loss than placebo.